Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

ICU TopicsResuscitation

ICU · Resuscitation

Vasoplegic and vasopressor-refractory shock: methylene blue, vasopressin, adjuncts

Also known as Vasoplegic shock · Vasopressor-refractory shock · Catecholamine-resistant shock · Methylene blue · Vasopressin · Refractory septic shock

Vasoplegic shock = distributive shock refractory to catecholamine vasopressors (noradrenaline) — profound NO-mediated vasodilation. Causes: septic shock (most common), post-cardiac surgery vasoplegia, anaphylaxis, post-reperfusion, drug-induced (ACEi, PDE inhibitors, protamine), adrenal insufficiency. PATHOPHYSIOLOGY: excessive nitric oxide (NO) production (iNOS induction in sepsis) → cGMP accumulation → vascular smooth muscle relaxation → vasodilation unresponsive to catecholamines. MANAGEMENT ESCALATION: (1) Adequate volume (but not over-resuscitate). (2) Noradrenaline (first-line alpha-1 agonist). (3) ADD VASOPRESSIN (V1 agonist — 0.03 U/min — catecholamine-sparing, different receptor). (4) ADD STEROIDS (hydrocortisone 200 mg/day — for CIRCI/adrenal insufficiency). (5) METHYLENE BLUE (1.5 mg/kg IV in the landmark RCT — inhibits NO-cGMP pathway — emerging for refractory vasoplegia). (6) Adjuncts: angiotensin II (ATHOS-3). High-dose vitamin C is not recommended (LOVIT). ALWAYS: treat cause, source control, exclude adrenal insufficiency/hypovolaemia.

high28 referencesUpdated 2 Sept 202632 min readSource-verified · Sept 2026

Checked against its sources on 2 Sept 2026

Practise this topic

  • 8 MCQs

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • Refractory to noradrenaline (>0.5 mcg/kg/min) → add vasopressin + steroids
  • Always exclude HYPOVOLAEMIA and ADRENAL INSUFFICIENCY before calling 'refractory'
  • Methylene blue (1.5 mg/kg IV in the landmark RCT) — emerging for refractory vasoplegia (NO-cGMP inhibitor)
  • Vasopressin 0.03 U/min — catecholamine-sparing (VANISH, VASST trials)
On this page
Study tools

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • Refractory to noradrenaline (>0.5 mcg/kg/min) → add vasopressin + steroids
  • Always exclude HYPOVOLAEMIA and ADRENAL INSUFFICIENCY before calling 'refractory'
  • Methylene blue (1.5 mg/kg IV in the landmark RCT) — emerging for refractory vasoplegia (NO-cGMP inhibitor)
  • Vasopressin 0.03 U/min — catecholamine-sparing (VANISH, VASST trials)
In one line

Vasoplegic shock = distributive shock refractory to catecholamines (NO-mediated vasodilation). ESCALATION: (1) Adequate volume (passive leg raise/fluid challenge — don't over-resuscitate). (2) Noradrenaline (first-line). (3) ADD vasopressin 0.03 U/min (VASST/VANISH — catecholamine-sparing, different receptor). (4) ADD hydrocortisone 200 mg/day (CIRCI). (5) Methylene blue 1.5 mg/kg IV in the landmark RCT (inhibits NO-cGMP — refractory vasoplegia). (6) Angiotensin II (ATHOS-3 — for refractory). ALWAYS exclude hypovolaemia + adrenal insufficiency first. Treat cause + source control.

[7] [8] [9] [10] [11] [19] [21]
ICU Fellowship (CICM) Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the ICU Fellowship (CICM) fellowship library.

Sign in to continueSee pricing
References28ShowHide
  1. [7]Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med, 2021.PMID 34599691
  2. [8]Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med, 2008.PMID 18305265
  3. [9]Gordon AC, Mason AJ, Thirunavukkarasu N, et al. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial. JAMA, 2016.PMID 27483065
  4. [10]Khanna A, English SW, Wang XS, et al. Angiotensin II for the Treatment of Vasodilatory Shock. N Engl J Med, 2017.PMID 28528561
  5. [11]Venkatesh B, Finfer S, Cohen J, et al. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock. N Engl J Med, 2018.PMID 29347874
  6. [12]Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. N Engl J Med, 2018.PMID 29490185
  7. [13]De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med, 2010.PMID 20200382
  8. [14]Asfar P, Meziani F, Hamel JF, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med, 2014.PMID 24635770
  9. [15]Meyhoff TS, Hjortrup PB, Wetterslev J, et al. Restriction of Intravenous Fluid in ICU Patients with Septic Shock. N Engl J Med, 2022.PMID 35709019
  10. [16]Shapiro NI, Douglas IS, Brower RG, et al. Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension. N Engl J Med, 2023.PMID 36688507
  11. [17]Lamontagne F, Masse MH, Menard J, et al. Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit. N Engl J Med, 2022.PMID 35704292
  12. [18]Levy B, Fritz C, Tahon E, et al. Vasoplegia treatments: the past, the present, and the future. Crit Care, 2018.PMID 29486781
  13. [19]Ng KT, Kwok PE, Lim WE, et al. The use of methylene blue in adult patients with septic shock: a systematic review and meta-analysis. Braz J Anesthesiol, 2025.PMID 39615751
  14. [20]Zhu MZL, Scullion J, Stroebel A, et al. Does methylene blue improve outcomes in patients with post-cardiac surgery vasoplegic syndrome? Interact Cardiovasc Thorac Surg, 2024.PMID 39731744
  15. [21]Levin RL, Degrange MA, Bruno GF, et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg, 2004.PMID 14759425
  16. [22]Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation, 1997.PMID 9054839
  17. [23]Vallabhajosyula S, Jentzer JC, Kotecha AA, et al. Development and performance of a novel vasopressor-driven mortality prediction model in septic shock. Ann Intensive Care, 2018.PMID 30467807
  18. [24]Cao F, Yan T, Liang C, et al. Sepsis-induced cardiomyopathy: mechanisms, epidemiology, diagnosis, and treatments. Front Immunol, 2026.PMID 41890740
  19. [25]Leone M, Myatra SN, Dugar S, et al. Clinical criteria for the definition of refractory septic shock: a joint Delphi consensus from the Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM). Intensive Care Med, 2026.PMID 41874620
  20. [26]Annane D, Cariou A, Maxime V, et al. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA, 2010.PMID 20103758
  21. [27]Tongyoo S, Chayakul C, Aritajati T, et al. Adjunctive terlipressin versus placebo in the treatment of refractory septic shock: a randomized, placebo-controlled trial. Crit Care, 2025.PMID 41121365
  22. [28]Polyak P, Kwak J, Kertai MD, et al. Vasoplegic Syndrome in Cardiac Surgery: A Narrative Review of Etiologic Mechanisms and Therapeutic Options. J Cardiothorac Vasc Anesth, 2025.PMID 40157894
  23. [29]Bauer ME, Pacheco LD Sepsis and Septic Shock During Pregnancy and Postpartum. Obstet Gynecol, 2025.PMID 40570351
  24. [30]Myburgh JA, Higgins A, Jovanovska A, et al. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med, 2008.PMID 18654759
  25. [31]Stanford SC, Stanford BJ, Gillman PK Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium. J Psychopharmacol, 2010.PMID 19423610
  26. [32]Chan CM, Mitchell AL, Shorr AF, et al. Etomidate is associated with mortality and adrenal insufficiency in sepsis: a meta-analysis. Crit Care Med, 2012.PMID 22971586
  27. [33]Petros A, Melkie A, Kotiso KS, et al. Peripheral line for vasopressor administration: Prospective multicenter observational cohort study for survival and safety. PLoS One, 2025.PMID 41082535
  28. [34]Cardona V, Ansotegui IJ, Ebisawa M, et al. World allergy organization anaphylaxis guidance 2020. World Allergy Organ J, 2020.PMID 33204386

Test yourself

Practise what you just read

  • 8 MCQs
ICU Fellowship (CICM) Pro

$29/ monthor $279 / year

The complete ICU Fellowship (CICM) library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousTrauma resuscitation and primary survey (ATLS)ResuscitationNextVenous thromboembolism prophylaxis in the ICUResuscitation